X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (84) 84
male (60) 60
middle aged (57) 57
female (56) 56
aged (41) 41
hypertension (38) 38
adult (36) 36
mortality (34) 34
malaysia (32) 32
cardiovascular diseases (30) 30
risk factors (29) 29
abridged index medicus (27) 27
cardiovascular disease (25) 25
medicine, general & internal (25) 25
studies (25) 25
risk (24) 24
blood pressure (23) 23
analysis (22) 22
prospective studies (21) 21
epidemiology (20) 20
prevention (20) 20
clinical medicine (19) 19
health risk assessment (18) 18
research (18) 18
stroke (18) 18
klinisk medicin (17) 17
population (17) 17
cardiovascular diseases - prevention & control (16) 16
blood-pressure (15) 15
cardiovascular diseases - epidemiology (15) 15
global health (15) 15
public, environmental & occupational health (15) 15
cardiac & cardiovascular systems (14) 14
developing countries (14) 14
prevalence (14) 14
cardiovascular diseases - mortality (13) 13
cardiovascular-disease (13) 13
medical research (13) 13
myocardial infarction (13) 13
clinical trials (12) 12
disease (12) 12
double-blind method (12) 12
diabetes (11) 11
income (11) 11
low-income countries (11) 11
management (11) 11
metaanalysis (11) 11
cardiovascular (10) 10
cardiovascular diseases - etiology (10) 10
developed countries (10) 10
health (10) 10
health aspects (10) 10
heart (10) 10
research article (10) 10
risk-factors (10) 10
socioeconomic factors (10) 10
care and treatment (9) 9
hypertension - drug therapy (9) 9
incidence (9) 9
internal medicine (9) 9
low income groups (9) 9
public health (9) 9
treatment outcome (9) 9
association (8) 8
cholesterol (8) 8
cross-sectional studies (8) 8
global burden (8) 8
health risks (8) 8
heart diseases (8) 8
hypertension - complications (8) 8
medical and health sciences (8) 8
medicin och hälsovetenskap (8) 8
medicine, experimental (8) 8
middle (8) 8
myocardial-infarction (8) 8
rural areas (8) 8
rural population - statistics & numerical data (8) 8
usage (8) 8
adults (7) 7
body mass index (7) 7
canada (7) 7
community (7) 7
coronary-heart-disease (7) 7
diet (7) 7
disease prevention (7) 7
dose-response relationship, drug (7) 7
education (7) 7
impact (7) 7
lipids (7) 7
malaysia - epidemiology (7) 7
medicine (7) 7
rural population (7) 7
therapy (7) 7
antihypertensive agents - therapeutic use (6) 6
cardiovascular diseases - physiopathology (6) 6
cerebral infarction (6) 6
consumer protection (6) 6
drug therapy (6) 6
drug therapy, combination (6) 6
endocrinology & metabolism (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Dokainish, Hisham and Teo, Koon and Zhu, Jun and Roy, Ambuj and AlHabib, Khalid F and ElSayed, Ahmed and Palileo-Villaneuva, Lia and Lopez-Jaramillo, Patricio and Karaye, Kamilu and Yusoff, Khalid and Orlandini, Andres and Sliwa, Karen and Mondo, Charles and Lanas, Fernando and Prabhakaran, Dorairaj and Badr, Amr and Elmaghawry, Mohamed and Damasceno, Albertino and Tibazarwa, Kemi and Belley-Cote, Emilie and Balasubramanian, Kumar and Islam, Shofiqul and Yacoub, Magdi H and Huffman, Mark D and Harkness, Karen and Grinvalds, Alex and McKelvie, Robert and Bangdiwala, Shrikant I and Yusuf, Salim and Campos, R and Chacón, C and Cursack, G and Diez, F and Escobar, C and Garcia, C and Vilamajo, O. Gomez and Hominal, M and Ingaramo, A and Kucharczuk, G and Pelliza, M and Rojas, A and Villani, A and Zapata, G and Bourke, P and Lanas, F and Nahuelpan, L and Olivares, C and Riquelme, R and Ai, F and Bai, X and Chen, X and Chen, Y and Gao, M and Ge, C and He, Y and Huang, W and Jiang, H and Liang, T and Liang, X and Liao, Y and Liu, S and Luo, Y and Lu, L and Qin, S and Tan, G and Tan, H and Wang, T and Wang, X and Wei, F and Xiao, F and Zhang, B and Zheng, T and Mendoza, J.L. Accini and Anaya, M. Blanquicett and Gomez, E and de Salazar, D.I. Molina and Quiroz, F and Rodríguez, M.J and Sotomayor, M. Suarez and Navas, A. Torres and León, M. Bravo and Montalvo, L.A. Falconi and Jaramillo, M. Lopez and Patiño, E. Peñaherrera and Perugachi, C and Trujillo Cruz, F and Elmaghawry, M and Wagdy, K and Bhardwaj, A.K and Chaturvedi, V and Gokhale, G. Krishna and Gupta, R and Honnutagi, R and Joshi, P and Ladhani, S and Negi, P.C and Roy, A and Reddy, N and Abdullah, A and Hassan, M.R. Abu and ... and INTER-CHF Investigators
The Lancet global health, ISSN 2214-109X, 2017, Volume 5, Issue 7, pp. e665 - e672
Summary Background Most data on mortality and prognostic factors in patients with heart failure come from North America and Europe, with little information... 
Internal Medicine | TRIAL | AFRICA | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | REDUCED EJECTION FRACTION | MANAGEMENT | COUNTRIES | CLINICAL CHARACTERISTICS | OUTCOMES | ASCEND-HF | ECONOMIC BURDEN | REGISTRY | Prospective Studies | Global Health | Humans | Middle Aged | Risk Factors | Female | Male | Aged | Hospitalization | Models, Statistical | Socioeconomic Factors | Heart Failure - mortality
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 386, Issue 9990, pp. 266 - 273
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 170, Issue 4, pp. 627 - 634.e1
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 388, Issue 10046, pp. 761 - 775
Summary Background Stroke is a leading cause of death and disability, especially in low-income and middle-income countries. We sought to quantify the... 
Internal Medicine | ETHNIC-DIFFERENCES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | CARDIOVASCULAR-DISEASE | ALCOHOL-CONSUMPTION | DIETARY PATTERNS | ISCHEMIC-STROKE | BURDEN | HEMORRHAGIC STROKE | BLOOD-PRESSURE | ATRIAL-FIBRILLATION | Humans | Middle Aged | Male | Apolipoproteins B - blood | Motor Activity | Cerebral Hemorrhage - blood | Hypertension - blood | Stroke - pathology | Brain Ischemia - blood | Obesity, Abdominal - epidemiology | Odds Ratio | Waist-Hip Ratio | Brain Ischemia - complications | Brain Ischemia - epidemiology | Risk Factors | Self Report | Atrial Fibrillation - complications | International Cooperation | Biomarkers - blood | Evidence-Based Medicine | Health Behavior | Stroke - etiology | Obesity, Abdominal - complications | Cerebral Hemorrhage - complications | Smoking - adverse effects | Africa - epidemiology | Case-Control Studies | Diabetes Complications - epidemiology | Adult | Female | Stroke - epidemiology | Hypertension - epidemiology | Diabetes Complications - prevention & control | Stroke - prevention & control | Risk Reduction Behavior | Europe - epidemiology | Feeding Behavior | China - epidemiology | Alcohol Drinking - adverse effects | Australia - epidemiology | Stroke - blood | Middle East - epidemiology | Asia - epidemiology | Atrial Fibrillation - epidemiology | Cerebral Hemorrhage - epidemiology | Alcohol Drinking - epidemiology | Smoking - epidemiology | Hypertension - complications | Aged | Apolipoprotein A-I - blood | Stroke (Disease) | Risk factors | Studies | Pathology | Stroke | Preventive medicine | Health risk assessment | Klinisk medicin | Clinical Medicine
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 388, Issue 10043, pp. 465 - 475
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Summary Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary... 
Internal Medicine | STROKE | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | THERAPY | MYOCARDIAL-INFARCTION | AVAILABILITY | HEART-FAILURE | SELF-REPORT | ACUTE CORONARY SYNDROMES | MEDICINES | VALIDITY | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9735, pp. 112 - 123
Journal Article